[Beta-galactosidase from E. coli as a marker in immunoenzyme analysis]

Area of Science:

• Biochemistry
• Molecular Biology
• Immunotechnology

Background:

• Enzyme immunoassay (EIA) is a widely used analytical technique.
• Sensitivity in EIA is crucial for detecting low concentrations of analytes.
• Beta-galactosidase is a versatile enzyme frequently employed as a label in EIA.

Purpose of the Study:

• To review factors influencing the sensitivity of enzyme immunoassays.
• To discuss the properties and applications of beta-galactosidase as a marker enzyme.
• To explore novel gene engineering strategies for EIA development.

Main Methods:

• Analysis of physico-chemical properties of beta-galactosidase.
• Discussion of various methods for preparing enzyme-antigen and enzyme-antibody conjugates.
• Review of homogeneous and heterogeneous EIA formats utilizing beta-galactosidase.
• Exploration of gene engineering techniques for creating enzyme-antigen fusions.

Main Results:

• Beta-galactosidase offers high sensitivity when used as a label in EIA.
• Chemical conjugation methods are established but have limitations.
• Gene engineering provides an alternative approach for creating enzyme-antigen fusions.
• Optimized EIA protocols can achieve high sensitivity for diverse compound analysis.

Conclusions:

• Factors influencing EIA sensitivity can be optimized through careful selection of enzyme labels and conjugation strategies.
• Beta-galactosidase is a highly effective label for sensitive immunoassays.
• Gene engineering presents a promising future direction for developing next-generation EIA systems.